Evidence map›Paper›PMID 39514509›Full record

ArticlePloS one2024

In vitro one-pot construction of influenza viral genomes for virus particle synthesis based on reverse genetics system.

Ryota Tanaka, Kenji Tamao, Mana Ono, Seiya Yamayoshi, Yoshihiro Kawaoka, Masayuki Su'etsugu, Hiroyuki Noji, Kazuhito V Tabata

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryota TanakaDepartment of Applied Chemistry, Graduate School of Engineering, the University of Tokyo, Tokyo, Japan.
Kenji TamaoDepartment of Applied Chemistry, Graduate School of Engineering, the University of Tokyo, Tokyo, Japan.
Mana OnoDepartment of Applied Chemistry, Graduate School of Engineering, the University of Tokyo, Tokyo, Japan.
Seiya YamayoshiDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Yoshihiro KawaokaDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Masayuki Su'etsuguDepartment of Life Science, College of Science, Rikkyo University, Tokyo, Japan.
Hiroyuki NojiDepartment of Applied Chemistry, Graduate School of Engineering, the University of Tokyo, Tokyo, Japan.
Kazuhito V TabataDepartment of Applied Chemistry, Graduate School of Engineering, the University of Tokyo, Tokyo, Japan.ORCID 0000-0002-0463-1374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reverse genetics system, which allows the generation of influenza viruses from plasmids encoding viral genome, is a powerful tool for basic research on viral infection mechanisms and application research such as vaccine development. However, conventional plasmid construction using Escherichia coli (E.coli) cloning is time-consuming and has difficulties handling DNA encoding genes toxic for E.coli or highly repeated sequences. These limitations hamper rapid virus synthesis. In this study, we establish a very rapid in vitro one-pot plasmid construction (IVOC) based virus synthesis. This method dramatically reduced the time for genome plasmid construction, which was used for virus synthesis, from several days or more to about 8 hours. Moreover, infectious viruses could be synthesized with a similar yield to the conventional E.coli cloning-based method with high accuracy. The applicability of this method was also demonstrated by the generation of recombinant viruses carrying reporter genes from the IVOC products. This method enables the pathogenicity analysis and vaccine development using genetically modified viruses, and it is expected to allow for faster analysis of newly emerging variants than ever before. Furthermore, its application to other RNA viruses is also expected.

Indexed as

Genome, ViralPlasmidsReverse GeneticsVirionAnimalsDogsEscherichia coliHumansMadin Darby Canine Kidney Cells

Identifiers

PMID39514509
PMCPMC11548778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.